The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence

Allergy and Asthma Proceedings

Volumn 29, Issue 2, 2008, Pages 140-145

  Santos, Carah B ^a   Hanks, Christopher ^a   McCann, Jeffrey ^a   Lehman, Erik B ^a   Pratt, Ellen ^a   Craig, Timothy J ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Complications; Double blinded; Fatigue; Montelukast; Perennial rhinitis; Placebo controlled; Quality of life; Rhinitis; Sleep; Somnolence

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIALLERGIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FATIGUE; HUMAN; IMMUNOLOGY; MIDDLE AGED; PERENNIAL RHINITIS; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER; SOMNOLENCE;

ACETATES; ADOLESCENT; ADULT; AGED; ANTI-ALLERGIC AGENTS; CROSS-OVER STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; DOUBLE-BLIND METHOD; FATIGUE; HUMANS; LEUKOTRIENE ANTAGONISTS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; QUINOLINES; RHINITIS, ALLERGIC, PERENNIAL; SLEEP DISORDERS;

EID: 43149113452     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3097     Document Type: Article

References (39)

1. Berger WE. Overview of allergie rhinitis. Ann Allergy Asthma Immunol 90(suppl 3):7-12, 2003.
2. Upton MN, McConnachie A, McSharry C, et al. Intergenerational 20-year trends in the prevalence of asthma and hay fever in adults: The Midspan Family study surveys of parents and offspring. BMJ 321:88-92, 2000.
3. Skoner DP. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 108(suppl 2):S2-S8, 2001.
4. Young T, Finn L, and Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 99(suppl):S757-S762, 1997.
5. Craig TJ, McCann JL, Gurevich F, and Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 114:S139-S145, 2004.
6. Blaiss M, Reigel T, and Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine. J Allergy Clin Immunol 115(suppl 2):S197, 2005.
7. Kakumanu S, Glass C, and Craig T. Poor sleep and daytime somnolence in allergic rhinitis: Significance of nasal congestion. Am J Respir Med 1:195-200, 2002.
8. Stuck BA, Czajkowski J, Hagner A-E, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: A controlled clinical trial. J Allergy Clin Immunol 113:663-668, 2004.
9. Stokes J, Fenstad E, and Casale T. Managing impairment in patients with allergic rhinitis. Allergy Asthma Proc 27:12-16, 2006.
10. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 99:S773-S780, 1997.
11. Thompson AK, Juniper E, and Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Immunol 85:338-348, 200.
12. Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc 21:7-13, 2000.
13. Meltzer EO. Clinical evidence for antileukotriene therapy in the management of allergic rhinitis. Ann Allergy Asthma Immunol 105:917-922, 2000.
14. Davies MJ, Fisher LH, Chegini S, and Craig TJ. A practical approach to allergic rhinitis and sleep disturbance management. Allergy Asthma Proc 27:224-230, 2006.
15. Meltzer EO, Philip G, Weinstein SF, et al. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol 19:591-598, 2005.
16. Blaiss M, Reigel T, and Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine. J Allergy Clin Immunol 115:5197, 2005 (Abs 787).
17. Young T, Finn L, and Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 99(suppl):S757-S762, 1997.
18. McNicholas WT, Tarlo S, Cole P, et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126:625-628, 1982.
19. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101:633-637, 1998.
20. Reinberg A, Gervais P, Levi F, et al. Circadian and circannual rhythms of allergic rhinitis: An epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol 81:51-62, 1988.
21. Lavie P, Gertner R, Zomer J, and Podoshin L. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol 92:529-533, 1981.
22. Suratt PM, Turner BL, and Wilhoit SC. Effect of intranasal obstruction on breathing during sleep. Chest 90:324-329, 1986.
23. Millman RP, Acebo C, Rosenberg C, and Carskadon MA. Sleep, breathing, and cephalometrics in older children and young adults. Part II-Response to nasal occlusion. Chest 109:673-679, 1996.
24. Jessen M, and Malm L. Definition, prevalence, and development of nasal obstruction. Allergy 52:3-6, 1997.
25. Nathan RA, Eccles R, Howarth PH, et al. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 115:S442-S459, 2005.
26. Chng SY, Goh DY, Wang XS, et al. Snoring and atopic disease: A strong association. Pediatr Pulmonol 38:210-216, 2004.
27. Sogut A, Altin R, Uzun L, et al. Prevalence of obstructive sleep apnea syndrome and associated symptoms in 3-11 year-old Turkish children. Pediatr Pulmonol 39:251-256, 2005.
28. McColley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 111:170-173, 1997.
29. Janson C, De Backer W, Gislason T, et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: A population study of young adults in three European countries. Eur Respir J 9:2132-2138, 1996.
30. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 68:435-443, 1969.
31. Goldbart AV, Goldman JL, Veling MC, and Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 172:364-370, 2005.
32. Juniper EF, and Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21:77-83, 1991.
33. Juniper EF, Stahl E, Doty RL, et al. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115:S390-S413, 2005.
34. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy 52:971-977, 1997.
35. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 162:1391-1396, 2000.
36. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99:S742-S749, 1997.
37. Meltzer EO, Nathan RA, Seiner JC, and Storms W. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 99:S815-S819, 1997.
38. Majani G, Baiardini I, Giardini A, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 56:313-317, 2001.
39. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 14:540-545, 1991.